Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Primary Meta-Analysis Across 10 RCTs (n= 366 ALC
All outcomes of interest were dichotomous, first preferentially extracting data from ClinicalTrials.gov and secondarily selecting data from the original trial publication or secondary analysis of the same trial
Semaglutide may be associated with the development of a new primary malignancy
The analyte concentrations are calculated automatically using the Chemoview software (API 4000 AB SCIEX)
US$ 29.80
US$ 28.94
US$ 20.96
US$ 29.85
US$ 28.72
US$ 25.86
